Progress on Multiplexed IHC CDx
Time: 5:15 pm
day: Day 1 - Track A (2)
Details:
- After long promise, multiplexing has matured from research to selection device driven by several late-stage clinical programs
- The combination of staining reagents and digital quantitation with advanced controls and calibrants have yielded systems that are highly reproducible and accurate
- This evolution has the potential to address the coming wave of new targeted ADC/IO therapies, positively improving trial outcomes and patient careÂ
